Pediatric cancer in the United States: The children's oncology group epidemiology research program

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 10, 2004, Pages 1552-1554

  Ross, Julie A ^a   Olshan, Andrew F ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RESEARCH; CHILD; CHILDHOOD CANCER; EDITORIAL; HUMAN; PRIORITY JOURNAL; UNITED STATES;

CHILD; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MULTICENTER STUDIES; NEOPLASMS; REGISTRIES; RESEARCH DESIGN; UNITED STATES;

EID: 4944224142     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Ries LA, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1975-2001. Bethesda: National Cancer Institute; 2004.
2. Pion SE, Peterson LE. Childhood cancer, heredity, and the environment. In: Pizzo P, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott-Raven; 1997. p. 11-36.
3. Ries LA, Smith MA, Gurney JG, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995, 99-4649. Bethesda (MD): National Cancer Institute, SEER Program; 1999.
4. Ross JA, Severson RK, Pollock BH, Robison LL. Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trial groups. Cancer 1996;77:201-7.
5. Slattery ML, Edwards SL, Caan BJ, Kerber RA, Potter JD. Response rates among control subjects in case-control studies. Ann Epidemiol 1995;5:245-9.
6. Ma X, Buffler PA, Layefsky M, Does MB, Reynolds P. Control selection strategies in case-control studies of childhood diseases. Am J Epidemiol 2004;159:915-21.
7. Ross JA, Spector LG, Olshan AF, Bunin GR. Invited commentary: birth certificates-a best control scenario? Am J Epidemiol 2004;159: 922-4; discussion 925.
8. Buck GM, Michalek AM, Chen CJ, Nasca PC, Baptiste MS. Perinatal factors and risk of neuroblastoma. Paediatr Perinat Epidemiol 2001; 15:47-53.
9. Infante-Rivard C, Krajinovic M, Labuda D, Sinnett D. Childhood acute lymphoblastic leukemia associated with parental alcohol consumption and polymorphisms of carcinogen-metabolizing genes. Epidemiology 2002;13:277-81.
10. Krajinovic M, Labuda D, Mathonnet G, et al. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin Cancer Res 2002;8:802-10.
11. Krajinovic M, Sinnett H, Richer C, Labuda D, Sinnett D. Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer 2002; 97:230-6.
12. Wiemels JL, Pagnamenta A, Taylor GM, Eden OB, Alexander FE, Greavies MF. A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study investigators. Cancer Res 1999;59:4095-9.
13. Davies SM, Bhatia S, Ross JA, et al. Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood 2002;100:67-71.
14. Ma X, Buffler PA, Selvin S, et al. Daycare attendance and risk of childhood acute lymphoblastic leukaemia. Br J Cancer 2002;86:1419-24.
15. UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study: objectives, materials and methods. Br J Cancer 2000;82:1073-102.